Heart Test Laboratories, Inc. (HSCSW) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Heart Test Laboratories, Inc. (HSCSW:NASDAQ), powered by AI.

Current Price
$0.07
Sector
Healthcare
What is the Heart Test Laboratories, Inc. stock price forecast?

Heart Test Laboratories, Inc. is currently trading at $0.07. View real-time AI analysis on Alpha Lenz.

What is Heart Test Laboratories, Inc. insider trading activity?

View the latest insider trading data for Heart Test Laboratories, Inc. on Alpha Lenz.

What is Heart Test Laboratories, Inc.'s P/E ratio?

View Heart Test Laboratories, Inc.'s valuation metrics on Alpha Lenz.

Heart Test Laboratories, Inc.

NASDAQ · HSCSW
$0.07+0.00(+0.00%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Heart Test Laboratories, Inc.'s future dividend policy...
Alpha Chat Insight

Heart Test Laboratories, Inc.'s ROE is -233.0%. Explore profitability and growth together.

Ask for details

Company Overview

Heart Test Laboratories, Inc., commonly known as HSCSW, is a company specializing in the development and commercialization of innovative medical devices designed to enhance cardiac care. Primarily, the company focuses on creating diagnostic tools that aid healthcare professionals in evaluating and monitoring heart health more effectively. One of their key products is a non-invasive diagnostic device engineered to deliver rapid, accurate assessments of cardiac conditions, thereby enabling timely intervention and management. Heart Test Laboratories operates within the broader medical technology and healthcare sectors, impacting both by providing crucial tools that advance patient outcomes and streamline clinical workflows. Its contributions are significant due to the increasing prevalence of cardiovascular diseases globally, which underscores the need for improved diagnostic techniques. In the financial market, Heart Test Laboratories plays a pivotal role by fueling innovation in healthcare diagnostics and contributing to the growth of the med-tech industry. The company's commitment to research and development underscores its strategic importance and potential impact on the way healthcare practitioners approach cardiac diagnostics and patient treatment.

CEOMr. Andrew Simpson
SectorHealthcare
IndustryMedical Devices
Employees15

Company Statistics

FY 2025

Profile

N/AMarket Cap
$4.35KRevenue
0.00Shares Out
15Employees

Margins

56.78%Gross
-187053.33%EBITDA
-192013.13%Operating
-201499.52%Pre-Tax
-201499.52%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

-32.86%Rev 3Yr
-41.63%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-127.72%ROA
-233.04%ROE
-120.42%ROIC

Financial Health

$1.10MCash & Cash Equivalents
$2.92MNet Debt
1958.24%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Heart Test Laboratories, Inc. (ticker: HSCSW) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 15 employees.

The current price is $0.071 with a P/E ratio of -x and P/B of -x.

ROE is -233.04% and operating margin is -192013.13%. Annual revenue is $4,350.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Heart Test Laboratories, Inc. (HSCSW) Stock Forecast 2026 $0.07 — Price, Financials & Analyst Targets | Alpha Lenz